Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1980 3
1981 6
1982 7
1983 17
1984 23
1985 20
1986 43
1987 32
1988 35
1989 32
1990 36
1991 56
1992 46
1993 29
1994 31
1995 23
1996 26
1997 25
1998 35
1999 31
2000 27
2001 25
2002 24
2003 43
2004 26
2005 37
2006 27
2007 28
2008 27
2009 36
2010 31
2011 31
2012 23
2013 26
2014 27
2015 24
2016 27
2017 24
2018 20
2019 19
2020 33
2021 26
2022 29
2023 24
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

1,184 results

Results by year

Filters applied: . Clear all
Page 1
Neuroleptic Malignant Syndrome.
Pileggi DJ, Cook AM. Pileggi DJ, et al. Ann Pharmacother. 2016 Nov;50(11):973-981. doi: 10.1177/1060028016657553. Epub 2016 Jul 19. Ann Pharmacother. 2016. PMID: 27423483 Review.
OBJECTIVE: To review evidence for the treatment of neuroleptic malignant syndrome (NMS) and to discuss how to rechallenge patients with neuroleptics when continued pharmacotherapy for chronic psychological illness is required. DATA SOURCES: A PubMed search wa …
OBJECTIVE: To review evidence for the treatment of neuroleptic malignant syndrome (NMS) and to discuss how to rechallen …
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective.
Tse L, Barr AM, Scarapicchia V, Vila-Rodriguez F. Tse L, et al. Curr Neuropharmacol. 2015;13(3):395-406. doi: 10.2174/1570159x13999150424113345. Curr Neuropharmacol. 2015. PMID: 26411967 Free PMC article. Review.
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response to treatment with antipsychotic drugs. ...Leading theories about the etiopathology of NMS are discussed, including the potential contributio …
Neuroleptic malignant syndrome (NMS) is a rare but potentially life-threatening side-effect that can occur in response …
Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
Perry PJ, Wilborn CA. Perry PJ, et al. Ann Clin Psychiatry. 2012 May;24(2):155-62. Ann Clin Psychiatry. 2012. PMID: 22563571 Review.
BACKGROUND: Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are uncommon but potentially life-threatening adverse reactions associated with psychotropic medications. ...Similarly, NMS presents as muscle rigidity, hyperpyrexia, mental status c …
BACKGROUND: Serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS) are uncommon but potentially life-threaten …
Neuroleptic malignant syndrome.
Moscovich M, Nóvak FT, Fernandes AF, Bruch T, Tomelin T, Nóvak EM, Munhoz RP, Teive HA. Moscovich M, et al. Arq Neuropsiquiatr. 2011 Oct;69(5):751-5. doi: 10.1590/s0004-282x2011000600005. Arq Neuropsiquiatr. 2011. PMID: 22042175 Free article. Review.
Neuroleptic malignant syndrome (NMS) is a potentially fatal adverse event associated with the use of antipsychotics (AP). ...As expected, more than two thirds of our cases were using classic AP (68%), however the clinical profile of these in comparison …
Neuroleptic malignant syndrome (NMS) is a potentially fatal adverse event associated with the use of antipsychotics (AP …
Quetiapine-Induced Neuroleptic Malignant Syndrome.
Saraiva R, Côrte-Real B, Cordeiro C, Gonçalves MJ, Abreu M, Coentre R. Saraiva R, et al. Prim Care Companion CNS Disord. 2023 Mar 23;25(2):22cr03332. doi: 10.4088/PCC.22cr03332. Prim Care Companion CNS Disord. 2023. PMID: 36963375 Free article. No abstract available.
Catatonia revived: a unique syndrome updated.
Mormando C, Francis A. Mormando C, et al. Int Rev Psychiatry. 2020 Aug-Sep;32(5-6):403-411. doi: 10.1080/09540261.2020.1723500. Epub 2020 Feb 18. Int Rev Psychiatry. 2020. PMID: 32067538 Review.
Catatonia occurs among various psychiatric, metabolic or neurologic conditions. It may present in many forms, including neuroleptic malignant syndrome. Treatment with benzodiazepines or electroconvulsive therapy usually produces dramatic and rapid response, a …
Catatonia occurs among various psychiatric, metabolic or neurologic conditions. It may present in many forms, including neuroleptic …
Neuroleptic malignant syndrome.
Kornhuber J, Weller M. Kornhuber J, et al. Curr Opin Neurol. 1994 Aug;7(4):353-7. doi: 10.1097/00019052-199408000-00013. Curr Opin Neurol. 1994. PMID: 7952245 Review.
Neuroleptic malignant syndrome (NMS) was first recognized as a life-threatening complication of dopamine receptor antagonists characterized by extrapyramidal disturbances, hyperthermia, and elevated serum creatine kinase levels. ...
Neuroleptic malignant syndrome (NMS) was first recognized as a life-threatening complication of dopamine receptor antag …
Drug-induced hyperthermia.
Chan TC, Evans SD, Clark RF. Chan TC, et al. Crit Care Clin. 1997 Oct;13(4):785-808. doi: 10.1016/s0749-0704(05)70369-9. Crit Care Clin. 1997. PMID: 9330841 Review.
This article reviews the pathophysiology, presentation, and treatment of several drug-induced hyperthermia syndromes: malignant hyperthermia, neuroleptic malignant syndrome, sympathomimetic poisoning, and anticholinergic toxicity. ...
This article reviews the pathophysiology, presentation, and treatment of several drug-induced hyperthermia syndromes: malignant hyperthermia …
Neuroleptic Malignant Syndrome/Malignant Catatonia in Child Psychiatry: Literature Review and a Case Series.
Ghaziuddin N, Hendriks M, Patel P, Wachtel LE, Dhossche DM. Ghaziuddin N, et al. J Child Adolesc Psychopharmacol. 2017 May;27(4):359-365. doi: 10.1089/cap.2016.0180. Epub 2017 Feb 23. J Child Adolesc Psychopharmacol. 2017. PMID: 28398818 Review.
OBJECTIVE: To describe the presentation of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) in children and adolescents. ...
OBJECTIVE: To describe the presentation of neuroleptic malignant syndrome (NMS) and malignant catatonia (MC) in childre …
1,184 results